Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

1.

Cooperation between Epstein-Barr Virus Immune Evasion Proteins Spreads Protection from CD8+ T Cell Recognition across All Three Phases of the Lytic Cycle.

Quinn LL, Zuo J, Abbott RJ, Shannon-Lowe C, Tierney RJ, Hislop AD, Rowe M.

PLoS Pathog. 2014 Aug 21;10(8):e1004322. doi: 10.1371/journal.ppat.1004322. eCollection 2014 Aug.

PMID:
25144360
[PubMed - as supplied by publisher]
2.

Counteracting effects of cellular Notch and Epstein-Barr virus EBNA2: implications for stromal effects on virus-host interactions.

Rowe M, Raithatha S, Shannon-Lowe C.

J Virol. 2014 Aug 13. pii: JVI.01431-14. [Epub ahead of print]

PMID:
25122803
[PubMed - as supplied by publisher]
3.

Epstein Barr virus entry; kissing and conjugation.

Shannon-Lowe C, Rowe M.

Curr Opin Virol. 2014 Feb;4:78-84. doi: 10.1016/j.coviro.2013.12.001. Epub 2014 Feb 16.

PMID:
24553068
[PubMed - in process]
4.

Epstein-Barr virus-mediated transformation of B cells induces global chromatin changes independent to the acquisition of proliferation.

Hernando H, Islam AB, Rodríguez-Ubreva J, Forné I, Ciudad L, Imhof A, Shannon-Lowe C, Ballestar E.

Nucleic Acids Res. 2014 Jan;42(1):249-63. doi: 10.1093/nar/gkt886. Epub 2013 Oct 3.

PMID:
24097438
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

The B cell transcription program mediates hypomethylation and overexpression of key genes in Epstein-Barr virus-associated proliferative conversion.

Hernando H, Shannon-Lowe C, Islam AB, Al-Shahrour F, Rodríguez-Ubreva J, Rodríguez-Cortez VC, Javierre BM, Mangas C, Fernández AF, Parra M, Delecluse HJ, Esteller M, López-Granados E, Fraga MF, López-Bigas N, Ballestar E.

Genome Biol. 2013 Jan 15;14(1):R3. doi: 10.1186/gb-2013-14-1-r3.

PMID:
23320978
[PubMed - in process]
Free PMC Article
6.

Epstein-Barr virus infection of naïve B cells in vitro frequently selects clones with mutated immunoglobulin genotypes: implications for virus biology.

Heath E, Begue-Pastor N, Chaganti S, Croom-Carter D, Shannon-Lowe C, Kube D, Feederle R, Delecluse HJ, Rickinson AB, Bell AI.

PLoS Pathog. 2012;8(5):e1002697. doi: 10.1371/journal.ppat.1002697. Epub 2012 May 10.

PMID:
22589726
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Deciphering the role of Epstein-Barr virus in the pathogenesis of T and NK cell lymphoproliferations.

Fox CP, Shannon-Lowe C, Rowe M.

Herpesviridae. 2011 Sep 7;2:8. doi: 10.1186/2042-4280-2-8.

PMID:
21899744
[PubMed]
Free PMC Article
8.

Cytotoxic CD4+ T cell responses to EBV contrast with CD8 responses in breadth of lytic cycle antigen choice and in lytic cycle recognition.

Long HM, Leese AM, Chagoury OL, Connerty SR, Quarcoopome J, Quinn LL, Shannon-Lowe C, Rickinson AB.

J Immunol. 2011 Jul 1;187(1):92-101. doi: 10.4049/jimmunol.1100590. Epub 2011 May 27.

PMID:
21622860
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Epstein-Barr virus infection of polarized epithelial cells via the basolateral surface by memory B cell-mediated transfer infection.

Shannon-Lowe C, Rowe M.

PLoS Pathog. 2011 May;7(5):e1001338. doi: 10.1371/journal.ppat.1001338. Epub 2011 May 5.

PMID:
21573183
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

A novel latent membrane 2 transcript expressed in Epstein-Barr virus-positive NK- and T-cell lymphoproliferative disease encodes a target for cellular immunotherapy.

Fox CP, Haigh TA, Taylor GS, Long HM, Lee SP, Shannon-Lowe C, O'Connor S, Bollard CM, Iqbal J, Chan WC, Rickinson AB, Bell AI, Rowe M.

Blood. 2010 Nov 11;116(19):3695-704. doi: 10.1182/blood-2010-06-292268. Epub 2010 Jul 29.

PMID:
20671118
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults characterized by high viral genome load within circulating natural killer cells.

Fox CP, Shannon-Lowe C, Gothard P, Kishore B, Neilson J, O'Connor N, Rowe M.

Clin Infect Dis. 2010 Jul 1;51(1):66-9. doi: 10.1086/653424.

PMID:
20504238
[PubMed - indexed for MEDLINE]
Free Article
12.

The effects of maribavir on the autophosphorylation of ganciclovir resistant mutants of the cytomegalovirus UL97 protein.

Shannon-Lowe CD, Emery VC.

Herpesviridae. 2010 Dec 7;1(1):4. doi: 10.1186/2042-4280-1-4.

PMID:
21429239
[PubMed]
Free PMC Article
13.

Stage-specific inhibition of MHC class I presentation by the Epstein-Barr virus BNLF2a protein during virus lytic cycle.

Croft NP, Shannon-Lowe C, Bell AI, Horst D, Kremmer E, Ressing ME, Wiertz EJ, Middeldorp JM, Rowe M, Rickinson AB, Hislop AD.

PLoS Pathog. 2009 Jun;5(6):e1000490. doi: 10.1371/journal.ppat.1000490. Epub 2009 Jun 26.

PMID:
19557156
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Features distinguishing Epstein-Barr virus infections of epithelial cells and B cells: viral genome expression, genome maintenance, and genome amplification.

Shannon-Lowe C, Adland E, Bell AI, Delecluse HJ, Rickinson AB, Rowe M.

J Virol. 2009 Aug;83(15):7749-60. doi: 10.1128/JVI.00108-09. Epub 2009 May 13.

PMID:
19439479
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

The Epstein-Barr virus G-protein-coupled receptor contributes to immune evasion by targeting MHC class I molecules for degradation.

Zuo J, Currin A, Griffin BD, Shannon-Lowe C, Thomas WA, Ressing ME, Wiertz EJ, Rowe M.

PLoS Pathog. 2009 Jan;5(1):e1000255. doi: 10.1371/journal.ppat.1000255. Epub 2009 Jan 2.

PMID:
19119421
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Hepatitis C virus association with peripheral blood B lymphocytes potentiates viral infection of liver-derived hepatoma cells.

Stamataki Z, Shannon-Lowe C, Shaw J, Mutimer D, Rickinson AB, Gordon J, Adams DH, Balfe P, McKeating JA.

Blood. 2009 Jan 15;113(3):585-93. doi: 10.1182/blood-2008-05-158824. Epub 2008 Oct 6.

PMID:
18838615
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Epstein-Barr virus exploits BSAP/Pax5 to achieve the B-cell specificity of its growth-transforming program.

Tierney R, Nagra J, Hutchings I, Shannon-Lowe C, Altmann M, Hammerschmidt W, Rickinson A, Bell A.

J Virol. 2007 Sep;81(18):10092-100. Epub 2007 Jul 11.

PMID:
17626071
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Epstein-Barr virus B95.8 produced in 293 cells shows marked tropism for differentiated primary epithelial cells and reveals interindividual variation in susceptibility to viral infection.

Feederle R, Neuhierl B, Bannert H, Geletneky K, Shannon-Lowe C, Delecluse HJ.

Int J Cancer. 2007 Aug 1;121(3):588-94.

PMID:
17417777
[PubMed - indexed for MEDLINE]
19.

Resting B cells as a transfer vehicle for Epstein-Barr virus infection of epithelial cells.

Shannon-Lowe CD, Neuhierl B, Baldwin G, Rickinson AB, Delecluse HJ.

Proc Natl Acad Sci U S A. 2006 May 2;103(18):7065-70. Epub 2006 Apr 10.

PMID:
16606841
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Epstein-Barr virus-induced B-cell transformation: quantitating events from virus binding to cell outgrowth.

Shannon-Lowe C, Baldwin G, Feederle R, Bell A, Rickinson A, Delecluse HJ.

J Gen Virol. 2005 Nov;86(Pt 11):3009-19.

PMID:
16227222
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk